Literature DB >> 10664896

GC/MS determination of zolpidem in postmortem specimens in a voluntary intoxication.

T Keller1, A Schneider, E Tutsch-Bauer.   

Abstract

An ingestion of an unknown quantity of Ivadal (zolpidem) tablets in a case of drug abuse is described. The authors report a new and fast method of analysing and determining the zolpidem concentration in postmortem specimens. Quantitation of zolpidem was performed by ethyl acetate extraction from alkalinized body fluids before GC/MS analysis. The analyses were performed without any complex sample clean-up steps and with little sample material. Postmortem concentrations of zolpidem in body fluids are given. The proposed method is a rapid procedure of analysis in cases of deliberate poisoning with the sedative-hypnotic drug, zolpidem.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10664896     DOI: 10.1016/s0379-0738(99)00185-1

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  4 in total

1.  Modulation and function of the autaptic connections of layer V fast spiking interneurons in the rat neocortex.

Authors:  William M Connelly; George Lees
Journal:  J Physiol       Date:  2010-03-29       Impact factor: 5.182

2.  Zolpidem : Forensic aspects for the toxicologist and pathologist.

Authors:  Timothy P Rohrig; Christine M Moore
Journal:  Forensic Sci Med Pathol       Date:  2005-06       Impact factor: 2.456

3.  Development and Validation of a Stability-Indicating Capillary Electrophoresis Method for the Determination of Zolpidem Tartrate in Tablet Dosage Form with Positive Confirmation using 2D- and 3D-DAD Fingerprints.

Authors:  Khaldun M Al Azzam; Lee Kam Yit; Bahruddin Saad; Hassan Shaibah
Journal:  Sci Pharm       Date:  2014-02-27

4.  Quantitation of zolpidem in biological fluids by electro-driven microextraction combined with HPLC-UV analysis.

Authors:  Saeid Yaripour; Ali Mohammadi; Isa Esfanjani; Roderick B Walker; Saeed Nojavan
Journal:  EXCLI J       Date:  2018-04-23       Impact factor: 4.068

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.